FindTrial
Sign In

HR17031 injection

DRUG5 trials

Sponsors

Jiangsu HengRui Medicine Co., Ltd.

Conditions

Adult Patients With Type 2 DiabetesAdult Patients With Type 2 Diabetes Uncontrolled on Oral Antidiabetic DrugsImproved Glycemic Control in Patients With Type 2 DiabetesType 2 Diabetes

Phase 1

A Trial of HR17031 Injection With Hepatic Insufficiency
NCT05151705
Jiangsu HengRui Medicine Co., Ltd.Improved Glycemic Control in Patients With Type 2 Diabetes
Start: 2021-12-20End: 2022-06-30Target: 24Updated: 2021-12-09
A Trial of HR17031 Injection With Renal Insufficiency
CompletedNCT05292495
Jiangsu HengRui Medicine Co., Ltd.Improved Glycemic Control in Patients With Type 2 Diabetes
Start: 2022-10-12End: 2024-04-10Updated: 2026-05-22

Phase 2

A Trial Comparing the Efficacy and Safety of HR17031 Injection to INS068 Injection and to SHR20004 Injection in Patients With Type 2 Diabetes
NCT05333835
Jiangsu HengRui Medicine Co., Ltd.Type 2 Diabetes
Start: 2022-07-08End: 2024-03-30Updated: 2023-04-25

Phase 3

A Trial Comparing HR17031 With Insulin Glargine in Patients With Type 2 Diabetes
CompletedNCT06871761
Jiangsu HengRui Medicine Co., Ltd.Adult Patients With Type 2 Diabetes
Start: 2024-05-08End: 2025-05-13Updated: 2026-01-13
A Study Comparing HR17031 With Insulin Glargine in Patients With Type 2 Diabetes
CompletedNCT06881264
Jiangsu HengRui Medicine Co., Ltd.Adult Patients With Type 2 Diabetes Uncontrolled on Oral Antidiabetic Drugs
Start: 2024-04-30End: 2025-09-19Updated: 2026-01-27